Thus, comparative effectiveness studies can be useful, at times both improving patient care and reducing medical costs.
President Obama is pushing "comparative effectiveness" studies that could pit pricey medical devices against cheap generic pills.
We have proposed a strategy of quality recommendations, with a public-private body that would do comparative effectiveness analysis.
Biopharmaceutical companies have been building such comparative effectiveness studies in their clinical development programs for the past decade.
FORBES: How Do Oncologists Sort Through All the New Anticancer Drugs?
This gap in knowledge is what comparative effectiveness studies are intended to address.
When Republicans tried to insert specific language in the stimulus bill prohibiting cost considerations in determining comparative effectiveness, Democrats shot that down.
FORBES: Avastin vs Lucentis: One Step Closer to Cost Rationing?
Mr Obama wants to expand comparative effectiveness studies and health technology assessments.
Comparative effectiveness research began in the late 1970s and, until the recent health care debate, for the most part enjoyed bipartisan political support.
Comparative effectiveness research involves running large, statistically robust clinical trials so we can judge how different therapies for a particular disease compare to each other.
FORBES: How Comparative Effectiveness Research Gets Corrupted by Politics
The 15-member Independent Medicare Advisory board will be formed amid concerns that it will arbitrarily turn down essential services based on overused so-called "comparative effectiveness" research.
Many conservatives reacted by arguing that comparative effectiveness research is bad, because it is a pretext for government interference in clinical practice, and for price controls.
FORBES: How Comparative Effectiveness Research Gets Corrupted by Politics
Nonetheless, I do believe that government, in the form of the National Institutes of Health, has a constructive role to play in funding comparative effectiveness research.
FORBES: How Comparative Effectiveness Research Gets Corrupted by Politics
They findings are likely to provide ammunition to legislators and doctors pushing for more "comparative effectiveness" studies to be done as part of health care reform.
The aim of comparative effectiveness is to reduce health care costs, an especially compelling goal for our government, the number one purchaser of medical treatments in America.
FORBES: What Standards Will Apply To Federal Drug 'Unsales' Force?
Comparative effectiveness research shows which treatments are more effective.
The Medicare Modernization Act of 2003, passed at a time when Republicans occupied the White House and controlled Congress, authorized the federal Agency for Healthcare Research and Quality to perform comparative effectiveness research.
Comparative effectiveness research has been done for years.
FORBES: Avastin vs Lucentis: One Step Closer to Cost Rationing?
He said that the growing use of comparative effectiveness research, which provides information on the relative strengths and weaknesses of different medical technologies, could help close the gap between what is known and what is done in pharmaceutical care.
FORBES: U.S. Patients Get Access To More Cancer Drugs, But Pay For The Privilege
But another more liberal school of thought, popularized by Obama's budget chief Peter Orszag, health advisor Ezekiel Emanuel and the new Medicare administrator Donald Berwick, says that the government should play a role in studying the "comparative effectiveness" of different treatment options.
Comparative effectiveness research is part of a plan to reallocate health care resources in a way similar to the U.K.'s National Institute for Health and Clinical Excellence, which uses "experts" to judge the cost-effectiveness of therapies, in order to decide which ones the government will pay for.
At its best, comparative-effectiveness research can give doctors and patients additional information on their treatment options.
FORBES: Obamacare's Rationers Employ The "It's Good For You" Defense
The United States Government will establish a division of labor with other bilateral, multilateral, and regional actors based on capacity, effectiveness, and comparative advantage.
WHITEHOUSE: Fact Sheet: U.S. Security Sector Assistance Policy
Britain and Germany are pioneering comparative reviews of drugs' effectiveness and cost-benefit analyses aimed at reimbursing firms for new drugs based on how well they perform.
应用推荐